Dokumentuaren aipamena

APA (7th ed.) Zitazioa
Hantash, E. M., Zahrani, A. A. A., & Serag, Y. R. (2024). Retinopathy of Prematurity (ROP)—Risk Factors and Therapeutic Effect of Intravitreal Injection of Bevacizumab (IVB): An Observational Study from a Neonatal Intensive Care Unit in Egypt. Wolters Kluwer Medknow Publications.
Chicago Style (17th ed.) Zitazioa
Hantash, Ehab Mohamed, Abdulrahman Abdullah Al Zahrani, eta Yasser Ragab Serag. Retinopathy of Prematurity (ROP)—Risk Factors and Therapeutic Effect of Intravitreal Injection of Bevacizumab (IVB): An Observational Study from a Neonatal Intensive Care Unit in Egypt. Wolters Kluwer Medknow Publications, 2024.
MLA (9th ed.) Zitazioa
Hantash, Ehab Mohamed, et al. Retinopathy of Prematurity (ROP)—Risk Factors and Therapeutic Effect of Intravitreal Injection of Bevacizumab (IVB): An Observational Study from a Neonatal Intensive Care Unit in Egypt. Wolters Kluwer Medknow Publications, 2024.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.